Section Arrow
NEO.NASDAQ
- NeoGenomics
Quotes are at least 15-min delayed:2026/07/11 00:57 EDT
Regular Hours
Last
 14.11
-0.62 (-4.21%)
Day High 
14.7 
Prev. Close
14.73 
1-M High
15.57 
Volume 
1.38M 
Bid
13.69
Ask
14.54
Day Low
13.955 
Open
14.7 
1-M Low
10.05 
Market Cap 
1.92B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 14.55 
20-SMA 12.9 
50-SMA 10.81 
52-W High 15.57 
52-W Low 4.72 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.77/-0.61
Enterprise Value
2.32B
Balance Sheet
Book Value Per Share
6.36
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
727.33M
Operating Revenue Per Share
4.41
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DHRDanaher Corp199.05+3.07+1.57%37.98PE
PSNLPersonalis14.07-0.58-3.96%-- 
QGENQiagen NV41.51-0.48-1.14%21.4PE
SHCSotera Health Company18.42+0.03+0.16%44.85PE
AAgilent Technologies134.29+0.7+0.52%26.83PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing,interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.